AGL Insider Trading

Insider Ownership Percentage: 2.69%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

ANGLE Insider Trading History Chart

This chart shows the insider buying and selling history at ANGLE by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ANGLE Share Price & Price History

Current Price: GBX 2.35
Price Change: Price Decrease of -0.3 (-11.32%)
As of 10/28/2025 01:28 PM ET

This chart shows the closing price history over time for AGL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

ANGLE Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2023Ian F GriffithsInsiderBuy37,500GBX 29£10,875
See Full Table

SEC Filings (Institutional Ownership Changes) for ANGLE (LON:AGL)

17.48% of ANGLE stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

ANGLE logo
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Read More on ANGLE

Today's Range

Now: GBX 2.35
Low: 2.33
High: 2.90

50 Day Range

MA: GBX 2.29
Low: 1.74
High: 2.82

52 Week Range

Now: GBX 2.35
Low: 1.50
High: 17.45

Volume

1,682,496 shs

Average Volume

1,623,727 shs

Market Capitalization

£7.58 million

P/E Ratio

N/A

Dividend Yield

1.12%

Beta

0.22